Overview

  • Product nameAnti-CLEC1B antibody
    See all CLEC1B primary antibodies
  • Description
    Goat polyclonal to CLEC1B
  • Specificityab81983 is expected to recognize both reported isoforms (NP_001092901.1; NP_057593.3)
  • Tested applicationsSuitable for: WB, ELISAmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide:

    KGHKCSPCDTNWRY

    , corresponding to internal sequence amino acids 95-108 of Human CLEC1B (NP_001092901.1; NP_057593.3).

  • Positive control
    • Human bone marrow and human kidney lysates.

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • Storage bufferPreservative: 0.02% Sodium Azide
    Constituents: 0.5% BSA, Tris saline, pH 7.3
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • Purification notesPurified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab81983 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB
ELISA
  • Application notesELISA: antibody detection limit dilution 1/1000.
    WB: Use at a concentration of 1 - 3 µg/ml. Predicted molecular weight: 27 kDa.


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionActs as a receptor for the platelet-aggregating snake venom protein rhodocytin. Rhodocytin binding leads to tyrosine phosphorylation and this promotes the binding of spleen tyrosine kinase (Syk) and initiation of downstream tyrosine phosphorylation events and activation of PLC-gamma-2. Acts as an attachment factor for human immunodeficiency virus type 1 (HIV-1) and facilitates its capture by platelets.
    • Tissue specificityExpressed preferentially in the liver. Also expressed in immune cells of myeloid origin and on the surface of platelets.
    • Sequence similaritiesContains 1 C-type lectin domain.
    • Post-translational
      modifications
      Glycosylated.
      Phosphorylated on tyrosine residue in response to rhodocytin binding.
    • Cellular localizationMembrane.
    • Information by UniProt
    • Database links
    • Alternative names
      • 1810061I13Rik antibody
      • C type lectin domain family 1 member B antibody
      • C type lectin like receptor 2 antibody
      • C-type lectin domain family 1 member B antibody
      • C-type lectin domain family 1, member B antibody
      • C-type lectin-like receptor 2 antibody
      • C-type lectin-like receptor-2 antibody
      • CLC1B_HUMAN antibody
      • CLEC 2 antibody
      • CLEC 2B antibody
      • CLEC-2 antibody
      • CLEC1B antibody
      • CLEC2 antibody
      • CLEC2B antibody
      • PRO1384 antibody
      • QDED721 antibody
      see all

    Anti-CLEC1B antibody images

    • Anti-CLEC1B antibody (ab81983) at 1 µg/ml + human kidney lysate (in RIPA buffer) at 35 µg
      Developed using the ECL technique

      Predicted band size : 27 kDa
      Observed band size : 30 kDa (why is the actual band size different from the predicted?)


      Exposure time : 1 hour

    References for Anti-CLEC1B antibody (ab81983)

    ab81983 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab81983.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"